01931.HK
IVD Medical Holding Limited
HKSE · Healthcare · Medical - Distribution · CN
HKD 0.56
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.0B | 2.8B | 3.2B | 3.1B | 2.7B |
| Cost of Revenue | 4.7B | 2.3B | 2.4B | 2.4B | 2.1B |
| Gross Profit | 1.3B | 566.4M | 751.2M | 671.7M | 608.1M |
| Operating Expenses | |||||
| R&D Expense | 13.3M | 13.3M | 7.4M | 8.7M | 7.2M |
| SG&A Expense | 685.6M | 380.5M | 305.1M | 296.3M | 272.9M |
| General & Admin Expense | 386.2M | 220.9M | 165.3M | 160.0M | 152.9M |
| Selling & Marketing Expense | 299.4M | 159.5M | 139.8M | 136.3M | 117.2M |
| Other Expenses | (9.9M) | 5.6M | (22.9M) | (958.0K) | 293.0K |
| Total Operating Expenses | 689.0M | 399.4M | 289.6M | 304.0M | 280.4M |
| Cost and Expenses | 5.4B | 2.7B | 2.7B | 2.7B | 2.4B |
| Operating Income (EBIT) | 628.5M | 167.0M | 461.6M | 367.7M | 327.8M |
| Non-Operating | |||||
| Interest Income | 6.5M | 1.8M | 2.7M | 2.9M | 2.0M |
| Interest Expense | 94.9M | 60.7M | 36.0M | 21.0M | 30.6M |
| Net Interest Income | (91.5M) | (58.9M) | (33.3M) | (18.1M) | (28.6M) |
| Other Non-Op Income/Expense | (138.5M) | (78.8M) | (59.8M) | (28.4M) | (44.0M) |
| Non-Operating Income (excl Interest) | 10.5M | (13.3M) | 23.8M | 7.3M | (7.2M) |
| EBT (Pre-Tax Income) | 490.0M | 88.2M | 401.8M | 339.3M | 283.8M |
| Income Tax Expense | 186.6M | 50.8M | 135.7M | 102.2M | 88.3M |
| Bottom Line | |||||
| Net Income | 295.4M | 34.9M | 260.4M | 238.2M | 210.0M |
| Earnings from Cont. Ops | 303.4M | 37.4M | 266.0M | 237.1M | 195.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 295.4M | 34.9M | 260.4M | 238.2M | 210.0M |
| Per Share | |||||
| Basic EPS | HK$0.21 | HK$0.02 | HK$0.17 | HK$0.18 | HK$0.16 |
| Diluted EPS | HK$0.21 | HK$0.02 | HK$0.17 | HK$0.18 | HK$0.16 |
| Revenue Per Share | HK$3.70 | HK$1.74 | HK$2.12 | HK$2.28 | HK$2.04 |
| Shares | |||||
| Basic Shares Outstanding | 1.6B | 1.6B | 1.5B | 1.4B | 1.3B |
| Diluted Shares Outstanding | 1.6B | 1.6B | 1.5B | 1.4B | 1.4B |
| Profitability Metrics | |||||
| EBITDA | 681.9M | 207.3M | 476.0M | 397.9M | 349.7M |
| D&A | 63.8M | 27.0M | 38.2M | 37.6M | 35.3M |
| EBIT | 618.1M | 180.3M | 437.8M | 360.4M | 314.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025